Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
General24 hours agoVictorian school teacher charged with soliciting child abuse material
-
General15 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News21 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News19 hours agoPalestine protesters forced into last-minute reroute